Study of Arimoclomol in Inclusion Body Myositis (IBM)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mazen Dimachkie, MD
University of Kansas Medical Center
Principal Investigator - Michael Hanna, MD
University College, London
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University College of London
London, United Kingdom
- Phoenix Neurological Associates
Phoenix, Arizona, United States
- University of California, Irvine
Irvine, California, United States
- University of Colorado School of Medicine
Aurora, Colorado, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Rochester
Rochester, New York, United States
- the Ohio State University
Columbus, Ohio, United States
- Nerve and Muscle Center of Texas
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Aug 2017
- Primary completion
- 11 Jan 2021
- Completion
- 11 Jan 2021
- Last update posted
- 10 May 2023
- Registered enrollment
- 152
- Registry id
- NCT02753530
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.